Business

Heavy hearts soared Monday with news that Moderna’s Covid-19 vaccine candidate — the frontrunner in the American market — seemed to be generating an immune response in Phase 1 trial subjects. The company’s stock valuation also surged, hitting $29 billion, an astonishing feat for a company that currently sells zero products. But was there good
0 Comments
Ground operations employees load baggage onto a Southwest Airlines Boeing 737 aircraft on the tarmac at John Wayne Airport (SNA) in Santa Ana, California. Patrick T. Fallon | Bloomberg | Getty Images Southwest Airlines said Tuesday that new bookings are outpacing cancellations, a turning point in the pandemic that has devastated air travel demand. The Dallas-based
0 Comments
Ford started resuming vehicle production in the U.S. on May 18, 2020 with new coronavirus safety protocols such as health assessments, personal protective equipment and facility modifications to increase social distancing. Ford The Detroit automakers on Monday started producing vehicles in the U.S. for the first time since late-March, but there are no guarantees that
0 Comments
U.S. President Donald Trump speaks during an event at the White House in Washington, D.C., U.S., on Friday, May 15, 2020. Stefani Reynolds | Bloomberg | Getty Images President Donald Trump said Monday that he has been taking anti-malaria drug hydroxychloroquine for over a week to prevent coronavirus infection even though it is not yet
0 Comments
Moderna‘s closely watched early-stage human trial for a coronavirus vaccine produced Covid-19 antibodies in all 45 participants, the biotech company announced Monday, sending the company’s shares surging as much as 30% in premarket trading. Each participant received a 25 microgram, 100 mcg or 250 mcg dose, with 15 people in each dose group. Study participants received
0 Comments